There is no age limit for methadone: a retrospective cohort study
2011

Aging Trends in Methadone Patients in Basel-City

Sample size: 958 publication Evidence: moderate

Author Information

Author(s): Dürsteler-MacFarland Kenneth M, Vogel Marc, Wiesbeck Gerhard A, Petitjean Sylvie A

Primary Institution: Psychiatric Hospital of the University of Basel

Hypothesis

This study aims to evaluate the age trends and related developments in the methadone population of Basel-City, Switzerland.

Conclusion

The study found a significant increase in older methadone patients in Basel-City, indicating a trend comparable to developments in US methadone populations.

Supporting Evidence

  • The percentage of patients aged 50 and over rose almost tenfold from 1996 to 2003.
  • The proportion of patients aged under 30 dropped significantly from 52.8% to 12.3% during the same period.
  • The average methadone dose and the 1-year retention rate also increased significantly.

Takeaway

The number of older patients on methadone is growing, and we need to pay more attention to their specific health needs.

Methodology

The study analyzed anonymized data from the methadone register of Basel-City for patients between April 1, 1995, and March 31, 2003, comparing age distributions across different years.

Limitations

The study did not include all patients registered for MMT in Basel-City and relied on a retrospective approach with limited information.

Participant Demographics

The study included methadone patients from various age categories, with a significant increase in those aged 50 and over.

Statistical Information

P-Value

p < 0.001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1747-597X-6-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication